Heme oxygenase-1 expression in chronic rhinosinusitis with eosinophilic infiltration

Auris Nasus Larynx

Volumn 39, Issue 4, 2012, Pages 387-392

  Kawano, Kenji ^a   Kusunoki, Takeshi ^a   Ono, Noritsugu ^a   Yao, Toru ^a   Saito, Tatsuya ^a   Yokoi, Hidenori ^a   Ikeda, Katsuhisa ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic rhinosinusitis; Eosinophilic infiltration; Heme oxygenase (HO) 1; Macrophage; Nasal polyps

Indexed keywords

EOSIN; HEMATOXYLIN; HEME OXYGENASE 1;

ADULT; AGED; ARTICLE; CHRONIC RHINOSINUSITIS WITH EOSINOPHILIC INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; NOSE POLYP; PROTEIN EXPRESSION; RHINOSINUSITIS; STAINING; TISSUE FIXATION;

ADULT; AGED; ASTHMA; CHRONIC DISEASE; EOSINOPHILS; EPITHELIAL CELLS; FEMALE; HEME OXYGENASE-1; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS;

EID: 84860307088     PISSN: 03858146     EISSN: 18791476     Source Type: Journal    
DOI: 10.1016/j.anl.2011.10.001     Document Type: Article

References (24)

1. Ponka P. Cell biology of heme. Am J Med Sci 1999, 318:241-256.
2. Choi A.M.K., Alam L. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996, 15:9-19.
3. Horvath I., Loukides S., Wodehouse T., Kharitonov S.A., Cole P.J., Baranes P.J. Increased levels of exhaled carbon monoxide in bronchiectasis: a new maker of oxidative stress. Thorax 1998, 53:867-870.
4. Suzuki H., Ikeda K., Honma R., Gotoh S., Oshima T., Furukawa M., et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. ORL 2000, 62:121-127.
5. Suzuki H., Ikeda K. Mode of action of long-term low-dose macrolide therapy for chronic sinusitis in the light of neutrophil recruitment. Curr Drug Targets Inflamm Allergy 2002, 1:117-126.
6. Vento S.I., Ertama L.O., Hytonen E.A., Wolff C.H.J., Malmberg H.O. Nasal polyposis clinical course during 20 years. Ann Allergy Asthma Immunol 2000, 85:209-214.
7. Katten M., Gergen P.J., Eggleston P., Visness C.M., Mitchell H.E. Health effects of indoor nitrogen dioxide and passive smoking on urban asthmatic children. Allery Clin Immunol 2007, 120:618-624.
8. Marcinkiewicz J., Ciszek M., Bobek M., Strus M., Heczko P.B., Kurnyta M., et al. Differential inflammatory mediator response in vitro from murine macrophages to lactobacilli and pathogenic intestinal bacteria. Int J Exp Pathol 2007, 88:155-164.
9. Elhini A., Abdelwanhab S., Ikeda K. Heme oxygenase (HO)-1 is upregulated in the nasal mucosa with allergic rhinitis. Laryngoscope 2006, 119:446-450.
10. Fokkens W., Lund V., Mullol J. European position paper on rhinosinusitis and nasal polyps. Rhinology 2007, 45:1-139.
11. Nonaka M., Pawankar R., Saji F., Yagi T. Distinct expression of RANTES and GM-CSF by lipopolysaccharide in human nasal fibroblasts but not in other airway fibroblasts. Int Arch Allergy Immunol 1999, 119:314-321.
12. Saitoh T., Kusunoki T., Yao T., Kawano K., Kojima Y., Miyashita K., et al. Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis. Rhinology 2009, 47:275-279.
13. Locksley R.M., Wilson C.B., Klebanoff S.J. Role for endogenous and acquired peroxidase in the toxoplasamacidal activity of murine and human mononuclear phagocytes. J Clin Invest 1982, 69:1099-1111.
14. Togaya E., Tamaoki J. Mechanisms of airway remodeling in asthma. Allergol Int 2007, 56:331-340.
15. Okada S., Kita H., George T.J., Gleich G.J., Leiferman K.M. Migration of eosinophils through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol 1997, 17:519-528.
16. Wenzel S.E., Schwartz L.B., Langmack E.L., Halliday J.L., Trudeau J.B., Gibbs R.L., et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999, 160:1001-1008.
17. Vendrow A.E., Hakim Z.S., Madamanchi N.R., Rojas M., Madamanchi C., Runge M.S. Atherosclerosis is attenuated by limiting superoxide generation in both macrophages and vessel wall cells. Aterioscler Thromb Vasc Biol 2007, 27:2714-2721.
18. Iijima M.K., Kobayashi T., Kamada H., Shimojo N. Exposure to ozone aggravates nasal allergy-like symptoms in guinea pigs. Toxicol Lett 2001, 123:77-85.
19. Otterbein L., Sylvester S.L., Choi A.M. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol 1995, 13:595-601.
20. Kitada O., Kodama T., Kuribayashi K., Ihaku M., Fujita T., Matsuyama T., et al. Heme oxygenases-1 (HO-1) protein induction in a mouse model of asthma. Clin Exp Allergy 2001, 31:1470-1477.
21. Horvath I., Donnelly L.E., Kiss A., Paredi P., Kharitonov S.A., Barnes P.J. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998, 53:668-672.
22. Xia Z.W., Xu L.Q., Zhong W.W., Wei J.J., Li N.L., Shao J., et al. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor-1. Am J Pathol 2007, 171:1904-1914.
23. Kim D., Kim S.H., Park E.J., Kang C.Y., Cho S.H., Kim S. Anti-allergic effects of PG102, a water-soluble extract prepared from Actinidia arguta, in a murine ovalbumin-induced asthma model. Clin Exp Allergy 2009, 39:280-289.
24. Pae H.O., Lee Y.C., Chung H.T. Heme oxygenase-1 and carbon monoxide: emerging therapeutic targets in inflammation and allergy. Recent Pat Inflamm Allergy Drug Discov 2008, 2:159-165.